Remsima SC Captures 22% of European Market, 5 Fold Growth in 4 Years 송영두 2025.05.28 오전 10:01 Bio&Pharma Stocks: BL Pharmtech, Celltrion and Amicogen on the Rise 임정요 2025.02.27 오전 08:33 Celltrion, Track to Achieve 5 Trillion won in Annual Revenue This Year with Successful U.S. Expan... 신민준 2025.03.06 오전 10:10 Celltrion's Remsima becomes S.Korea's first 'blockbuster' drug 임정요 2025.02.27 오전 08:36 로딩중..
RemsimaSC
RemsimaSC
